Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

SpePharm gets €16mm in private round

Executive Summary

SpePharm Holdings BV (cancer and critical care therapeutics) raised €16mm ($23.6mm) through a private financing from TVM Capital, Signet Healthcare Partners, Paul Capital Healthcare, and members of the company's senior management team. SpePharm concurrently announced a €10mm revenue interest acquisition financing agreement signed with Paul Capital to fund the recent purchase of European rights to Dantrium for hyperthermia from Procter & Gamble.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies